Search results
... in UK Highlight Brexit Challenges - AstraZeneca (NASDAQ:AZN), Johnson & Johnson (NYSE:JNJ), GSK...
Benzinga· 1 week agoDrug shortages in the UK have more than doubled between 2020 and 2023, a recent study by the...
AstraZeneca’s Lynparza to remain dominant in PARP inhibitors market with $4 billion in sales by 2027
BioPharma-Reporter· 1 day agoWhile the PARP inhibitors market has seen increasing competition over the years, Lynparza is set to...
What's Driving AstraZeneca PLC's Surprising 14% Stock Rally?
Guru Focus· 1 day agoAstraZeneca PLC (AZN, Financial) has recently seen a notable uptick in its stock performance, with a market capitalization now standing at a robust $231.04 billion. Over the ...
Mergers and Acquisitions in 2024: A Cautious Recovery With Strategic Shifts | Daily Business Review
Law.com· 5 days agoAfter a sluggish 2023, mergers and acquisitions activity has so far exhibited a cautious but...
Inflation Reduction Act to have knock on effect on R&D, say biotech experts
Pharmaceutical Technology via Yahoo Finance· 1 day agoThe Biden Administration is facing multiple lawsuits launched by pharma companies and industry...
Takeda Pharmaceutical: A Long-Term Cash Cow
GuruFocus.com via Yahoo Finance· 4 days agoAn additional investment thesis we highlight is Takeda's dividend yield, which is about 4.46%, outperforming its key competitors such as Johnson & ...
...Market Towards US$ 15.89 Bn by 2030 | Rising Mental Health Awareness and New Therapeutic Options...
Digital Journal· 12 hours agoThe global anxiety disorder treatment market size is projected to grow from $12 billion in 2022 to...
Uveitis History Linked to Recurrence After COVID Vaccination
MedPage Today· 2 days agoThe risk was especially high in the initial 30 days after the first shot as compared with the...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 4 days agoNEW YORK, April 22, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm ...
...Expected to Reach USD 13.64 Billion by 2030 Predicts SNS Insider | Leading Companies – Abbott,...
Digital Journal· 13 hours agoThe global Type 1 Diabetes Market, which was valued at USD 7.59 billion in 2022, is anticipated to...
